ADIPOQ and metabolic dysfunction-associated steatotic liver disease: In human studies, low levels of circulating adiponectin have been associated with NAFLD [148,149], and rodent studies show that adiponectin knockout mice develop more severe high-fat-diet-induced hepatic steatosis [150].